OTC
Arcturus Therapeutics provides update on OTC deficiency and CF programmes
July 2, 2024Research and Development Arcturus Therapeutics, OTC, Pharmacy, clinical trials, cystic fibrosis
Arcturus Therapeutics has announced mid-year updates for ARCT-810, an investigational mRNA therapeutic to treat ornithine transcarbamylase (OTC) deficiency, and ARCT-032, …
FDA approves a second OTC naloxone nasal spray
July 31, 2023Medical Communications FDA, Nasal Spray, OTC, OTC Products, naloxone, opioids
The US Food and Drug Administration (FDA) has announced that it has approved RiVive, 3mg naloxone hydrochloride nasal spray for …
FDA approves first OTC daily oral contraceptive pill
July 14, 2023Medical Communications Contraception, FDA, OTC, Opill, contraceptive pill
The US Food and Drug Administration (FDA) has announced that it has approved the Opill (norgestrel) tablet for nonprescription use …
FDA advisory committee votes in favour of OTC contraceptive pill
May 11, 2023Medical Communications Contraception, FDA, OTC, Perrigo, contraception
Perrigo Company has announced that the US Food and Drug Administration’s (FDA) Nonprescription Drugs Advisory Committee (NDAC) and the Obstetrics, …
Throat lozenges could be contributing to antimicrobial resistance
April 12, 2019Medical Communications AMR, Antibiotics, OTC, WHO, antimicrobial, health
Over the counter (OTC) throat lozenges could be contributing to antimicrobial resistance (AMR) according to research presented at this year’s …
GSK and Pfizer combine healthcare units in multibillion dollar deal
December 19, 2018Research and Development GSK, OTC, Pfizer, healthcare, merger
American multinational Pfizer and British firm GlaxoSmithKline are set to combine their consumer healthcare units in a venture worth billions. …
Bayer opens OTC drug plant in China
January 19, 2016Manufacturing and Production Bayer, China, OTC, TCM, Yunnan, over the counter, traditional Chinese medicine
Bayer has opened a new manufacturing plant to produce over-the-counter (OTC) drugs in China, as the German firm looks to …
OTC drugs market boosted by growing patient demand
December 24, 2015Manufacturing and Production, Sales and Marketing GBI Research, OTC, generics, over the counter
Increasing pressures from customers, drug manufacturers and regulators to convert prescription medications to over-the-counter (OTC) non-prescription status is driving growth …
Global drug spending will rise 30% by 2020, to $1.4 trillion
November 18, 2015Research and Development IMS Health, OTC, drug spending, emerging markets, generics, prescribing
Global spending on drugs will increase 30% to $1.4 trillion by 2020, as more patients get access to treatments and …
Mylan appoints a global commercial lead for OTC business
November 3, 2015Manufacturing and Production Mylan, OTC, Ranjan Ray Chaudhuri, over the counter
Mylan has appointed Ranjan Ray Chaudhuri as its new global commercial lead for the company’s over-the-counter (OTC) business. Chaudhuri will …
J&J pleads guilty over children’s contaminated medicine
March 12, 2015Manufacturing and Production, Sales and Marketing FDA, J&J, JJ, McNeil, OTC, Tylenol, consta, hamburg, recall
Johnson & Johnson’s consumer division McNeil has pleaded guilty and will pay fines of $25 million for wrongdoings regarding its …
Cialis OTC approval sought
June 2, 2014Sales and Marketing Cialis, ED, OTC, Sanofi, lilly
Sanofi and Eli Lilly have announced they are to push ahead with plans to seek regulatory approval for erectile dysfunction …
Bayer concludes $14bn Merck consumer care takeover
May 7, 2014Sales and Marketing Bayer, Merck, OTC, consumer care, merger
Bayer has confirmed its acquisition of US firm Merck’s over-the-counter (OTC) portfolio in a deal worth $14 billion. The arrangement …
GSK increases India stake
March 11, 2014Manufacturing and Production, Sales and Marketing FDA, GSK, India, Nashik, OTC, Thane, bangalore
GlaxoSmithKline has taken a further step into the Indian pharma market by increasing its stake in its subsidiary company there, …
